Fortress Biotech, Inc. (FBIO)
2.93
+0.06
(+2.09%)
USD |
NASDAQ |
Aug 24, 16:00
2.93
0.00 (0.00%)
After-Hours: 20:00
Fortress Biotech Market Cap : 97.60M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 97.60M |
| August 21, 2026 | 95.60M |
| August 20, 2026 | 92.27M |
| August 19, 2026 | 94.94M |
| August 18, 2026 | 96.94M |
| August 17, 2026 | 93.94M |
| August 14, 2026 | 97.60M |
| August 13, 2026 | 99.27M |
| August 12, 2026 | 91.61M |
| August 11, 2026 | 86.94M |
| August 10, 2026 | 91.26M |
| August 07, 2026 | 88.61M |
| August 06, 2026 | 91.93M |
| August 05, 2026 | 92.59M |
| August 04, 2026 | 90.27M |
| August 03, 2026 | 91.60M |
| July 31, 2026 | 103.87M |
| July 30, 2026 | 109.18M |
| July 29, 2026 | 111.18M |
| July 28, 2026 | 112.50M |
| July 27, 2026 | 108.52M |
| July 24, 2026 | 110.84M |
| July 23, 2026 | 113.83M |
| July 22, 2026 | 117.81M |
| July 21, 2026 | 117.15M |
| Date | Value |
|---|---|
| July 20, 2026 | 110.51M |
| July 17, 2026 | 111.51M |
| July 16, 2026 | 113.50M |
| July 15, 2026 | 123.12M |
| July 14, 2026 | 123.79M |
| July 13, 2026 | 109.52M |
| July 10, 2026 | 109.52M |
| July 09, 2026 | 109.18M |
| July 08, 2026 | 99.56M |
| July 07, 2026 | 99.23M |
| July 06, 2026 | 97.90M |
| July 02, 2026 | 100.89M |
| July 01, 2026 | 102.55M |
| June 30, 2026 | 101.55M |
| June 29, 2026 | 97.90M |
| June 26, 2026 | 91.60M |
| June 25, 2026 | 100.22M |
| June 24, 2026 | 104.21M |
| June 23, 2026 | 104.87M |
| June 22, 2026 | 102.22M |
| June 18, 2026 | 99.23M |
| June 17, 2026 | 101.88M |
| June 16, 2026 | 97.24M |
| June 15, 2026 | 94.91M |
| June 12, 2026 | 91.93M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Inovio Pharmaceuticals, Inc. | 102.93M |
| Ironwood Pharmaceuticals, Inc. | 682.44M |
| Kura Oncology, Inc. | 1.103B |
| Spero Therapeutics, Inc. | 70.65M |
| Cue Biopharma, Inc. | 121.22M |
Market Cap Related Metrics
| PE Ratio | 1.103 |
| PS Ratio | 1.441 |
| Price to Book Value | 0.5946 |
| Price to Free Cash Flow | 0.8201 |
| Price | 2.93 |
| Earnings Yield | 90.67% |
| Normalized PE Ratio | 1.197 |